Vasopressors & Inotropes

Dopamine

Patient-specific bag-prep worksheet for a 100 mL dopamine drip. The 6×kg shortcut adds 6 mg/kg of stock to a 100 mL bag, yielding a concentration where the pump rate in mL/hr equals the dose in µg/kg/min. No further math at the bedside. Used for inotropic and vasopressor support in hypotension and shock once fluid status is adequate.

Stock: 40 mg/mL (40 000 µg/mL)
  • High-alert medication. Do NOT confuse DOPamine with DOBUTamine or DOXapram (Doprap).
  • Volume status first. Volume depletion should be corrected before dopamine administration. Vasopressors are not a substitute for adequate fluid replacement.
How this calculator works

Uses the 6 × kg method: add (6 × patient weight in kg) mg of dopamine to a 100 mL bag of compatible IV fluid. Once mixed, the pump rate in mL/hr is equal to the dose in µg/kg/min, no further math at the bedside.

Don't have a 100 mL bag? The 6×kg shortcut requires a 100 mL bag specifically (the elegant pump-rate-equals-dose identity is bag-size dependent). If you only have 250 mL or 500 mL bags available, use the standard dopamine CRI calculator →

Dogs: 3–20 µg/kg/min (start 2.5–5, titrate +2.5–5 every ~30 min). Cats: 5–20 µg/kg/min, same titration.
Awaiting input

Enter a patient weight to see the result.

Reference

How the calculation works

The 6 × kg method produces a bag where pump rate (mL/hr) equals dose (µg/kg/min). The bag concentration is derived as:

$$\text{concentration} = \frac{6 \times \text{BW}_{\text{kg}} \times 1000\,\mu g/mg}{100\,\text{mL}} = 60 \times \text{BW}_{\text{kg}}\;\mu g/\text{mL}$$

At that concentration, a dose of D µg/kg/min requires:

$$\text{mL/hr} = \frac{\text{BW}_{\text{kg}} \times D_{\mu g/kg/min} \times 60}{60 \times \text{BW}_{\text{kg}}} = D$$

So pump rate (mL/hr) and dose (µg/kg/min) are numerically equal, no further bedside math needed.

Worked example with current inputs

Enter a patient weight to see the worked example.

Enter a patient weight to see the worked example.

Reference

The 6 × kg method

The preparation worksheet specifies:

  1. Multiply patient weight in kg by 6, that's the milligrams of dopamine to add.
  2. From a 40 mg/mL stock vial, draw the equivalent volume.
  3. Remove that same volume from a 100 mL bag of compatible IV fluid first, then add the dopamine.
  4. Run the pump at mL/hr = dose in µg/kg/min.

Worked example

For a 10 kg patient: 6 × 10 = 60 mg of dopamine, which is 1.5 mL of 40 mg/mL stock. Remove 1.5 mL from a 100 mL bag, then add 1.5 mL of dopamine. To dose at 5 µg/kg/min, run the pump at 5 mL/hr.

Why this works

A 100 mL bag with (6 × BW) mg of dopamine has concentration (6 × BW × 1000) ÷ 100 = 60 × BW µg/mL. For a dose D µg/kg/min, total drug needed per hour is BW × D × 60 µg. Divided by the concentration: (60 × BW × D) ÷ (60 × BW) = D mL/hr.

Limits and stability

  • The final dopamine concentration is capped at 3,200 µg/mL (3.2 mg/mL). The 6 × kg method exceeds this for patients above ~53 kg; at that point, switch to a 250 mL or 500 mL bag with proportionally more dopamine.
  • Stable for 24 hours at 20–25°C after dilution. Discard if discolored beyond slightly yellow.
  • Administer through a dedicated IV line into a large vein. Extravasation causes tissue necrosis.
  • Stepwise dose reduction prior to discontinuation reduces rebound hypotension risk.

Compatible fluids

5% / 10% dextrose, lactated Ringer's, 5% dextrose in LRS or 0.9% NaCl, 6% hetastarch, Plasma-Lyte, 0.9% NaCl.

Contraindications and cautions

  • Contraindicated: pheochromocytoma, ventricular fibrillation, uncorrected tachyarrhythmias.
  • Caution: ischemic or occlusive vascular disease; weaning from mechanical ventilation; oliguric acute kidney injury (low-dose dopamine is unlikely to benefit and may worsen renal vasoconstriction).
  • Discontinue or reduce dose if PVCs occur or if there are signs of reduced peripheral or cardiac perfusion.

Notable drug interactions

  • α-antagonists (acepromazine, prazosin): may decrease pressor effects.
  • β-antagonists (propranolol, metoprolol): combination causes unopposed α stimulation, raising SVR.
  • Inhalant anesthetics (isoflurane, sevoflurane): may increase arrhythmia risk.
  • MAOIs (amitraz, selegiline, linezolid): start dopamine at 1/10 the usual dose if MAOI given within 2–3 weeks.
  • Other sympathomimetics (dobutamine, terbutaline, etc.): toxicity risk if combined.

Sources

  • Primary: Plumb's Veterinary Drugs, dopamine monograph (Prescriber Highlights, Pharmacology/Actions, Pharmacokinetics, Contraindications/Precautions/Warnings, Adverse Effects, Drug Interactions, Dosages, Preparation/Stability, Administration sections).
  • Secondary (cat HCM/PVC concern): Lumb and Jones' Veterinary Anesthesia and Analgesia, 6th ed. Chapter 21 (Cardiovascular Drugs). Editor and full bibliographic details pending.
  • Secondary (clinical positioning): Hart S, Silverstein DC. Catecholamines. In: Silverstein DC, Hopper K, eds. Small Animal Critical Care Medicine. 3rd ed. St. Louis, MO: Elsevier; 2023:855–859 (Chapter 147, Table 147.1). Confirms the receptor-effect dose tiers (1–4 µg/kg/min dopaminergic; 5–10 µg/kg/min β; >10 µg/kg/min α) and provides the clinical context that dopamine is currently recommended as an alternative to norepinephrine only in highly selected patients (low risk of tachyarrhythmias, or absolute/relative bradycardia), its use in critically ill humans has been associated with significantly poorer outcomes and higher arrhythmic-event incidence than norepinephrine.